GTHP (Guided Therapeutics) Cyclically Adjusted Book per Share: $-747.27 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GTHP Guided Therapeutics Inc GTHP
25 GF Score
Price $0.22
GF Value $1.08
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Guided Therapeutics Cyclically Adjusted Book per Share?

Guided Therapeutics GTHP -13.03% 25 Cyclically Adjusted Book per Share is $-747.27 as of Jun. 2026. GuruFocus rates GTHP with a GF Score™ of 25/100 and a GF Value™ of $1.08 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Guided Therapeutics's adjusted book value per share for the three months ended in Jun. 2026 was $-0.067. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $-747.27 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Guided Therapeutics was 45.40% per year. The lowest was 9.60% per year. And the median was 15.60% per year.

As of today (2026-08-20), Guided Therapeutics's current stock price is $0.21655. Guided Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $-747.27. Guided Therapeutics's Cyclically Adjusted PB Ratio of today is .


Guided Therapeutics  (OTCPK:GTHP) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Guided Therapeutics Cyclically Adjusted Book per Share Related Terms


Guided Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Guided Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guided Therapeutics Cyclically Adjusted Book per Share Chart

Guided Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,158.48 -1,035.98 -923.04 -834.60 -764.31

Guided Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -804.26 -787.35 -764.31 -758.34 -747.27

GTHP vs PETV, FOFA, CTSO: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Guided Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guided Therapeutics Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Guided Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Guided Therapeutics's Cyclically Adjusted PB Ratio falls into.


GTHP
25GF Score
Guided Therapeutics Inc GTHP
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guided Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Guided Therapeutics's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.067/333.9520*333.9520
=-0.067

Current CPI (Jun. 2026) = 333.9520.

Guided Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.000 241.428 0.000
201612 -10,568.000 241.432 -14,617.800
201703 -5,133.500 243.801 -7,031.729
201706 -3,836.333 244.955 -5,230.149
201709 -1,123.083 246.819 -1,519.558
201712 -329.968 246.524 -446.989
201803 -109.191 249.554 -146.119
201806 -44.893 251.989 -59.495
201809 -31.200 252.439 -41.275
201812 -6.231 251.233 -8.283
201903 -5.066 254.202 -6.655
201906 -5.842 256.143 -7.617
201909 -5.672 256.759 -7.377
201912 -5.345 256.974 -6.946
202003 -1.056 258.115 -1.366
202006 -1.438 257.797 -1.863
202009 -1.255 260.280 -1.610
202012 -1.033 260.474 -1.324
202103 -0.893 264.877 -1.126
202106 -0.918 271.696 -1.128
202109 -0.879 274.310 -1.070
202112 -0.901 278.802 -1.079
202203 -0.498 287.504 -0.578
202206 -0.399 296.311 -0.450
202209 -0.134 296.808 -0.151
202212 -0.123 296.797 -0.138
202303 -0.116 301.836 -0.128
202306 -0.124 305.109 -0.136
202309 -0.128 307.789 -0.139
202312 -0.126 306.746 -0.137
202403 -0.126 312.332 -0.135
202406 -0.137 314.175 -0.146
202409 -0.131 315.301 -0.139
202412 -0.121 315.605 -0.128
202503 -0.093 319.799 -0.097
202506 -0.097 322.561 -0.100
202509 -0.087 324.800 -0.089
202512 -0.088 324.054 -0.091
202603 -0.061 330.213 -0.062
202606 -0.067 333.952 -0.067

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $-747.27 mean?
Guided Therapeutics (GTHP) has a Cyclically Adjusted Book per Share of $-747.27 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Guided Therapeutics and its competitors.
Is Guided Therapeutics' Cyclically Adjusted Book per Share too high?
Guided Therapeutics' current Cyclically Adjusted Book per Share is $-747.27. Overall, Guided Therapeutics has a GF Score™ of 25/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Guided Therapeutics' Cyclically Adjusted Book per Share compare to PETV and FOFA?
Guided Therapeutics' Cyclically Adjusted Book per Share of $-747.27 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Guided Therapeutics and its competitors. Guided Therapeutics's current Cyclically Adjusted Book per Share is $-747.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guided Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Guided Therapeutics (GTHP) is currently considered Possible Value Trap. The stock's GF Value™ is $1.08, compared to a current price of $0.22 — trading 79.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is $-747.27. Guided Therapeutics' overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Guided Therapeutics (GTHP), the current Cyclically Adjusted Book per Share is $-747.27 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guided Therapeutics (GTHP) Overvalued in 2026?

Based on GuruFocus' analysis, Guided Therapeutics stock appears to be undervalued. The current stock price of $0.22 is trading 79.9% below its estimated GF Value™ of $1.08. GuruFocus considers Guided Therapeutics to be Possible Value Trap.

Key valuation signals for GTHP:

  • Cyclically Adjusted Book per Share: $-747.27
  • GF Value™: $1.08 vs. price of $0.22 (79.9% below fair value)
  • GF Score™: 25/100 with 4 warning signs

No single metric tells the full story. See the GTHP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guided Therapeutics Business Description

Address 5835 Peachtree Corners East, Suite B, Peachtree Corners, GA, USA, 30092
Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and the extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.
25GF Score

Get the complete analysis for GTHP

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price
$1.08
GF Value